FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes novel derivatives of substituted pyrazine of the formula (I) where Ar is phenyl, naphthyl, indolyl, indolonyl, benzimidazolyl, quinolyl optionally substituted with one-three substitutes taken among the group described in the invention claim; Ar1 means phenyl, pyridinyl, pyridazinyl, pyrimidinyl or pyrazinyl optionally substituted with one-two substituted taken among the group described in the invention claim also, or their pharmaceutically acceptable salts. Invention relates to also the pharmaceutical composition inhibiting the process of dopamine binding with dopamine D4, receptors and method of inhibition of the process of dopamine binding with dopamine D4 receptors based on the compounds described. EFFECT: new compounds indicated above, valuable pharmacological properties. 31 cl, 2 tbl, 57 ex
Authors
Dates
2001-02-20—Published
1995-08-24—Filed